Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Lattice Biologics Ltd V.LBL.H

Alternate Symbol(s):  LBLTF

Lattice Biologics Ltd. is engaged in the business of developing, manufacturing and marketing biologics products to domestic and international markets. The Company’s products are used in a variety of applications including enhancing bone regeneration in dental, spine, and general orthopedic indications. Its acellular dermal matrix is used for dental flaps which is used to close defects post... see more

TSXV:LBL.H - Post Discussion

Lattice Biologics Ltd > Just More Info...........
View:
Post by colima on Apr 29, 2020 2:09pm

Just More Info...........

LOS ANGELES, April 29, 2020 (GLOBE NEWSWIRE) -- Capricor Therapeutics (Capricor) (NASDAQ: CAPR) a clinical-stage biotechnology company focused on the development of first-in-class biological therapeutics for the treatment and prevention of diseases, announced today new data reporting 100 percent survival in critical COVID-19 patients who were treated with Capricors lead asset, off-the-shelf (allogeneic) cardiac cell therapy CAP-1002, at Cedars-Sinai Medical Center as part of six compassionate care cases. Over the course of one month, six critically ill COVID-19 patients, all suffering from acute respiratory distress syndrome (ARDS) and five of whom were on mechanical ventilatory support, were safely treated with CAP-1002. Of the six patients treated, four of them have been discharged. Following a review of the available data, the U.S. Food and Drug Administration (FDA) approved the Companys expanded access protocol to treat up to 20 additional COVID-19 patients. There is also a randomized, placebo-controlled trial planned to treat patients with moderate and severe disease which is intended to be funded by non-equity capital.
Comment by colima on Apr 29, 2020 2:13pm
Even if you're on the right track, you'll get run over if you just sit there. ( a little humor from Will Rogers
Comment by Torontonine on Apr 29, 2020 2:46pm
Sell your shares and avoid getting run over by the train
Comment by colima on Apr 29, 2020 3:28pm
Too late Torontonine. I've already been run over and hanging on to the cattle guard. Keep averaging down and hoping for some news soon about LBLs' 100% cure rate.
Comment by Torontonine on Apr 29, 2020 3:36pm
Patience .. we are all hoping for same thing.
Comment by HarfanddesNeiges on Apr 29, 2020 3:48pm
Very calm today, hope LBL closes at 12 C
Comment by MaterialWorld on Apr 29, 2020 6:32pm
Be smart and hold .... this sucker will be the best investment you have ever made ..... MW
Comment by wintrader on Apr 29, 2020 7:33pm
Here is my wildest prediction so far :  Next week-end or before market opening monday , Lattice will put a smile on all our face with positive NR ! Longer the patience , bigger the reward !
Comment by Smiles62 on May 07, 2020 1:42am
still smiling?
Comment by gainwidpatience on Apr 29, 2020 2:52pm
Impressive from Capricor! LBL had stated since Mar 13. Need a NR here.
Comment by Nomoreshells4me on Apr 29, 2020 3:15pm
Rising tides lift all boats. This is great news for Capricor and all stem cell companies. I think Big pharma had put the sqeeze on the FDA in the past over stem cell until COVID-19. With people dying all over the world by the seconds it's hard to turn a blind eye. Big pharma can still win. All they have to do is buy the stem cell companies out and mass produce. Save the world , all it's ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities